Ranibizumab treatment administered as needed for occult and minimally classic neovascular membranes in age-related macular degeneration. (Q50525128)
Jump to navigation
Jump to search
scientific article published on 13 March 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Ranibizumab treatment administered as needed for occult and minimally classic neovascular membranes in age-related macular degeneration. |
scientific article published on 13 March 2011 |
Statements
Ranibizumab treatment administered as needed for occult and minimally classic neovascular membranes in age-related macular degeneration. (English)
1 reference
Seungbum Kang
1 reference
Young-Jung Roh
1 reference
13 March 2011
1 reference
55
1 reference
2
1 reference
123-127
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference